Targeting TIGIT Inhibits Bladder Cancer Metastasis Through Suppressing IL-32

Bladder cancer is a highly metastatic tumor and one of the most common malignancies originating in the urinary tract. Despite the efficacy of immune checkpoints, including programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), the effect of immunotherapy for bladder...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Kang, Zeng, Jun, Shi, Xulian, Xie, Jiajia, Li, Yuqing, Zheng, Haoxiang, Peng, Guoyu, Zhu, Guanghui, Tang, Dongdong, Wu, Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766971/
https://www.ncbi.nlm.nih.gov/pubmed/35069212
http://dx.doi.org/10.3389/fphar.2021.801493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766971/
https://www.ncbi.nlm.nih.gov/pubmed/35069212
http://dx.doi.org/10.3389/fphar.2021.801493

Ejemplares similares